UPDATE: Needham & Company Downgrades Verrica Pharmaceuticals (VRCA) to Hold
Tweet Send to a Friend
(Updated - May 25, 2022 11:25 AM EDT)
Needham & Company analyst Serge Belanger downgraded Verrica Pharmaceuticals (NASDAQ: VRCA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham & Company analyst Serge Belanger downgraded Verrica Pharmaceuticals (NASDAQ: VRCA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
